openPR Logo
Press release

DiGeorge Syndrome Drug Market 2020 Future Outlook | Key Players - Aevi Genomic Medicine, Bausch Health, Natera, Roche Sequencing, Enzyvant, Progenity, AbbVie, Amgen , Johnson & Johnson

DiGeorge Syndrome Drug Market

DiGeorge Syndrome Drug Market

The primary sources employed while generating this DiGeorge Syndrome Drug Market report include the industry experts from the industry comprising the management corporation, processing organizations, analytical service suppliers of the industry's value chain. All primary sources are interviewed to accumulate the data and validate qualitative & quantitative information and conclude future prospects. Secondary research consists of key data about the industry value chain, the complete pool of major players, and application areas. The DiGeorge Syndrome Drug Market report assist in market segmentation according to industry latest & upcoming trends to the bottom-most level, topographical markets and key advancement from both market and technology aligned perspectives.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-digeorge-syndrome-drug-market&rp

Market Analysis: Global DiGeorge Syndrome Drug Market

Global DiGeorge syndrome drug market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Growing incidence of DiGeorge syndrome's population and development of newer therapies and treatment are the key factors for market growth

Key Market Players: Global DiGeorge Syndrome Drug Market

Few of the major competitors currently working in the global Digeorge syndrome drug market are Aevi Genomic Medicine, Inc, Bausch Health, Natera, Inc, Roche Sequencing, Enzyvant, Progenity, Inc., Boehringer Ingelheim International GmbH, AbbVie Inc., Amgen Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services, Inc, Angimmune LLC, Sumitomo Dainippon Pharma Co., Ltd., CELGENE CORPORATION, CELLECTAR BIOSCIENCES, INC, eFFECTOR Therapeutics, Inc., IMV Inc, Karyopharm, Neon Therapeutics, Novartis AG and many others

Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/toc/?dbmr=global-digeorge-syndrome-drug-market&rp

Market Definition: Global DiGeorge Syndrome Drug Market

DiGeorge syndrome is also known as 22q11.2 deletion syndrome or velocardiofacial syndrome is a rare pediatric congenital condition where children are born with absence of chromosome 22. This results to severe immunodeficiency causing poor development of several body systems. Children with DiGeorge syndrome disorders have no ability to fight against infections.

According to the article puplished in Northwestern University, it is estimated that the incident population of DiGeorge Syndrome in the United States around 500 to 750 and over 2.5 million children diagnosed yearly. These growing incidents of DiGeorge syndrome's population worldwide and robust pipeline for development of newer therapies are the key factors for market growth.

Segmentation: Global DiGeorge Syndrome Drug Market

DiGeorge Syndrome Drug Market : By Therapy Type

Regenerative Medicine Advanced Therapy
Hormone Replacement Therapy

DiGeorge Syndrome Drug Market : By Treatment

Medication
Surgery
Palatoplasty

DiGeorge Syndrome Drug Market : By Route of administration

Oral
Injectable

DiGeorge Syndrome Drug Market : By End Users

Hospitals
Homecare
Specialty Clinics
Others

DiGeorge Syndrome Drug Market : By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market:

In June 2019, Enzyvant's drug candidate RVT-802, a tissue-based regenerative therapy received the FDA acceptance of Biologic License Application (BLA) as well as Priority Review status for the treatment of pediatric congenital athymia associated with complete DiGeorge Anomaly (cDGA), CHARGE syndrome, and FOXN1 deficiency. If approved, it will be the first drug used for the treatment of DiGeorge syndrome and turning it into a potential blockbuster commercial milestone for Enzyvant.
In September 2017, Enzyvant received Rare Pediatric Disease designation from the FDA for RVT-802, a tissue-based regenerative therapy for treatment of congenital athymia associated with complete DiGeorge Syndrome. The FDA Rare Pediatric Disease designation will enable to receive a rare pediatric disease priority review voucher upon approval of Biologic License Application (BLA).

DiGeorge Syndrome Drug Market Drivers

Vulnerable pediatric population of DiGeorge syndrome
Emergence of drugs for treating serious disease such as CNS disorders and cardiovascular diseases associated with DiGeorge syndrome
Increase in the rate of R&D initiatives is driving DiGeorge syndrome therapeutics market

DiGeorge Syndrome Drug Market Restraints

Effective treatment is either unavailable or unaffordable
Patent expiry from many companies and introduction of generic drugs of branded version is expected to restrain the growth if the market
Inadequate knowledge about DiGeorge syndrome in some developing countries

Reasons to Purchase this Report :

Current and future of global Digeorge syndrome drug market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players

DiGeorge Syndrome Drug Market analysis report offers strategic & tactical support to clients for making well-informed business decisions. DBMR team provides customization of this market report according to the business needs. Contact sales team, who will assure to get a report that suits the necessities. The report carefully examines the global DiGeorge Syndrome Drug Market, with a focus on most of the major players and their business strategies, geographical scope, market segments, product landscape and price, and cost structure. Such market report is made available for industries, individuals, and organizations across the globe, and offerings are delivered in the shortest possible turnaround time.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-digeorge-syndrome-drug-market&rp

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: Corporatesales@databridgemarketresearch.com
https://databridgemarketresearch.com

About Data Bridge Market Research :

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release DiGeorge Syndrome Drug Market 2020 Future Outlook | Key Players - Aevi Genomic Medicine, Bausch Health, Natera, Roche Sequencing, Enzyvant, Progenity, AbbVie, Amgen , Johnson & Johnson here

News-ID: 2065477 • Views: 495

More Releases from Data Bridge Market Research Pvt. Ltd.

Medical Device Testing Market 2020 (COVID -19 Impact Analysis) Industry Research …
This Medical Device Testing Market research report contains a comprehensive data of market definition, classifications, applications, engagements, market drivers and market restraints all of which are obtained from SWOT analysis. The market document presents key statistics on the market status of Global & Regional manufacturers and proves to be an important source of guidance and direction for companies and individuals interested in the industry. Information and data provided through the
Nebulizers Market 2020 (COVID -19 Impact Analysis) Industry Research, Share, Tre …
This Nebulizers Market research report contains a comprehensive data of market definition, classifications, applications, engagements, market drivers and market restraints all of which are obtained from SWOT analysis. The market document presents key statistics on the market status of Global & Regional manufacturers and proves to be an important source of guidance and direction for companies and individuals interested in the industry. Information and data provided through the Nebulizers Market
Medical Robots Transforming Healthcare Market 2020 (COVID -19 Impact Analysis) I …
This Medical Robots Transforming Healthcare Market research report contains a comprehensive data of market definition, classifications, applications, engagements, market drivers and market restraints all of which are obtained from SWOT analysis. The market document presents key statistics on the market status of Global & Regional manufacturers and proves to be an important source of guidance and direction for companies and individuals interested in the industry. Information and data provided through
Medical Device Ozone Sterilization Market 2020 (COVID -19 Impact Analysis) Indus …
This Medical Device Ozone Sterilization Market research report contains a comprehensive data of market definition, classifications, applications, engagements, market drivers and market restraints all of which are obtained from SWOT analysis. The market document presents key statistics on the market status of Global & Regional manufacturers and proves to be an important source of guidance and direction for companies and individuals interested in the industry. Information and data provided through

All 5 Releases


More Releases for DiGeorge

Prenatal DNA Sequencing Market Trends, Cost Structure Analysis, Growth Opportuni …
DNA sequencing is a process used to determine the order of nucleotides within DNA molecules. Prenatal DNA sequencing is the method of sequencing the DNA isolated from pregnant women’s blood to reveal the full genetic code of a fetus. Prenatal DNA sequencing is used to sequence the whole genome of unborn baby that effectively detects the diseases or disorder such as Down syndrome, cystic fibrosis, thalassemia and cancer. The wide
Global Primary Immunodeficiency Diseases Market US$ 7 Billion by 2023
The global primary immunodeficiency diseases market expected to reach US$ 7 billion by 2023, growing at CAGR 6.7% over the forecast period 2017-2021, due to higher incidence of primary immunodeficiency disorders worldwide. https://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/ The global primary immunodeficiency diseases market report estimates the market size in US$ million for 2015-2023, and forecasts growth trends over a period of 2018-2023. The market for key market segments has been estimated based on epidemiology approach
Global Metabotropic Glutamate Receptor 1 Sales Market Size, Analysis, Growth & F …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Metabotropic Glutamate Receptor 1 Sales Market Research Report 2018”which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% during stated forecast from 2018-2025. The report studies the Metabotropic Glutamate Receptor 1 Sales market worldwide, especially in North America, China,
Global Primary Immunodeficiency Diseases Market US$ 6.1 Billion by 2021
The global primary immunodeficiency diseases market expected to reach US$ 6.1 billion by 2021, growing at CAGR 6.7% over the forecast period 2017-2021, due to higher incidence of primary immunodeficiency disorders worldwide. Primary immunodeficiency diseases or disorders (PIDD or PI) are caused as part of the body's immune system is missing or does not function normally, such that it is an inherited flaw in the immune system that increases the
Global Primary Immunodeficiency Diseases Market US$ 6.1 Billion by 2021
Primary immunodeficiency diseases or disorders (PIDD or PI) are caused as part of the body's immune system is missing or does not function normally, such that it is an inherited flaw in the immune system that increases the susceptibility to infections. Besides susceptibility to infections, PIDD may cause other health problems as well, including allergies, asthma, swollen joints, digestive tract problems, growth problems or an enlarged liver and spleen. The
Primary Immunodeficiency Diseases Market : Trends, Opportunities and Forecasts u …
This report on the primary immunodeficiency diseases (PIDD) market studies the current as well as future prospects of the market. The stakeholders of this report include pharmaceuticals companies, diagnostic kits providers, distributors, care providers and insurance companies (payers) and other intermediaries engaged in PIDD as well as new entrants that are planning to enter in this segment. This report comprises an elaborate executive summary with a market snapshot providing overall